FILTER
FILTERED INTERVIEW RESULTS
Sudheendra Kulkarni
CEO, SOUTH ASIA & ASEAN FERRING PHARMACEUTICALS
Ferring is a global biopharmaceutical company based in Switzerland that has one of the most comprehensive footprints in India.
Milind Antani and Darren Punnen
LEAD - PHARMA, HEALTHCARE, MEDICAL SERVICE AND DIGITAL HEALTH PRACTICE & LEADER - PHARMA AND LIFE SCIENCES PRACTICE, NISHITH DESAI ASSOCIATES (NDA)
Practice, Nishith Desai Associates (NDA) speak about legal developments relating to India’s life sciences industry
Lakshmi Prasanna Chundu
DIRECTOR - REGULATORY AFFAIRS, THE PHARMACEUTICAL EXPORT PROMOTION COUNCIL OF INDIA (PHARMEXCIL)
Pharmexcil explains how the agency is promoting India’s life sciences exports, which aim to reach US$40 billion in five years.
Daara Patel
SECRETARY GENERAL, INDIAN DRUG MANUFACTURERS’ ASSOCIATION (IDMA)
"Today, India's pharmaceutical sector is a US$50 billion industry and we anticipate it growing to at least US$150 billion in less than a decade."
Roma Shah & Komal Doshi
CEO & DIRECTOR, EASTMEN CHEMICALS
Eastmen Chemicals is set on increasing its market beyond India.
Ravi Udaya Bhaskar
DIRECTOR GENERAL, PHARMEXCIL
India’s Pharmexcil discusses developments in the country’s pharmaceuticals segment.
Dr. Sharvil Patel
MANAGING DIRECTOR, ZYDUS CADILA
Zydus Cadila ranks fourth in the Indian pharmaceutical industry, with a strong global presence in the U.S., Europe, Latin America and South Africa, alongside 25 other emerging markets worldwide.
Dr. Kunal Saxena
MANAGING DIRECTOR, RUSAN PHARMA
Rusan Pharma is a fully integrated pharmaceutical company specializing in the treatment of addiction and pain management.
Neha Ramani
PARTNER, LEXORBIS
Lex Orbis provides IP and legal services to the life science industry in India and beyond and comments on the exciting evolution of technology and research in India.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Mexico Chemicals 2024
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
